Comparison
Saffron vs Chaga
Saffron
Crocus stigma — most expensive spice. Increasingly evidence-based antidepressant comparable to SSRIs at low doses.
Chaga
Birch-tree mushroom (Inonotus obliquus) traditionally used in Russia/Siberia for immune and antioxidant support.
| Field | Saffron | Chaga |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 28–30mg | 1000–3000mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 1700 | 280 |
The comparison in plain English
Auto-generated from dataSaffron and Chaga are both in the adaptogen category respectively. Saffron Crocus stigma — most expensive spice. Chaga Birch-tree mushroom (Inonotus obliquus) traditionally used in Russia/Siberia for immune and antioxidant support.
Bottom line
Saffron (evidence A, safety 4/5) has a weaker evidence base than Chaga (evidence B, safety 4/5). Saffron has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Saffron if
Saffron is the better fit when your goal aligns with its mechanism (Crocin (carotenoid responsible for the red colour) and safranal (volatile compound responsible for the aroma) both inhibit serotonin and dopamine reuptake at neurochemically meaningful concentrations) and the dose range (28–30mg) suits your protocol. Half-life is —h.
Choose Chaga if
Chaga is the better fit when your goal aligns with its mechanism (Polysaccharides (beta-glucans), betulinic acid (from the birch tree the fungus grows on), and melanin compounds contribute to antioxidant and immunomodulatory effects) and the dose range (1000–3000mg) suits your protocol. Half-life is —h.